均瑶健康股价三连板 一季度电商渠道销售激增1173%

Core Viewpoint - Junyao Health's stock has experienced a significant increase, with a cumulative rise of 33.23% over three consecutive trading days, despite the company's announcement that there have been no major changes in its main business operations [1][2]. Financial Performance - In Q1 of this year, Junyao Health reported a revenue increase of 1.41% year-on-year, but net profit decreased by 58.29% [1][3]. - For the year 2024, the company’s revenue was 1.458 billion yuan, a decline of 10.8%, and it recorded a net loss of 29.12 million yuan, a decrease of 150.6% year-on-year [3]. - The traditional beverage business has shown weak performance, contributing to the overall revenue decline, while the probiotic business has demonstrated strong growth, accounting for 54.3% of total revenue in 2024 [3]. E-commerce Growth - Junyao Health has seen explosive growth in its e-commerce channels, with sales increasing by 177.49% in 2024 and a staggering 1173.33% in Q1 of 2025 [4]. - The company has optimized its product layout and focused on market demand, enhancing its competitiveness in online channels [4]. International Market Performance - In 2024, Junyao Health achieved approximately 84.6 million yuan in revenue from overseas markets, reflecting a year-on-year growth of 24.54%, with Q1 of 2025 showing a significant increase of 77.43% [4]. Future Growth Drivers - The company aims to strengthen its beverage core business, expand probiotic health products, and increase raw material exports, leveraging its proprietary strain resources and production capacity [5][6].